A clinical trial to evaluate and compare the blood levels of two aliskiren modified release formulations with aliskiren market tablet in healthy adult subjects
Not Applicable
Completed
- Registration Number
- CTRI/2011/12/002235
- Lead Sponsor
- ovartis Healthcare Private Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 42
Inclusion Criteria
1. Healthy Subjects
2. Female subejcts must be of non-child bearing potential
3. Subjects must weigh at least 50kg & their BMI 18 to 30 kg/m2 for participation
Exclusion Criteria
1. Smokers
2. History of hypersensitivity to any of the study drugs or to drugs of similar chemical classes
3. Pregnant or nursing (lactating) women
4. Impaired hepatic or relnal function test results
5. A positive Hepatitis B surface antigen (HBsAg) or Hepatitis C test result
Study & Design
- Study Type
- BA/BE
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method